Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research focused on Cancer research and Cyclin-dependent kinase 6, with related work in Microbiome, microRNA, Gut flora. Notable publications include 'Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence', 'A comprehensive review on microbiome, aromas and flavors, chemical composition, nutrition and future prospects of Fuzhuan brick tea', and '<p>microRNA-612 suppresses the malignant development of non-small-cell lung cancer by directly targeting bromodomain-containing protein 4</p>'.
IINS Vs CALLY Index: A Battle of Prognostic Value in NSCLC Patients Following Surgery
FLT3LG modulates the infiltration of immune cells and enhances the efficacy of anti-PD-1 therapy in lung adenocarcinoma
FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression
Identification of Increased Grain Length 1 (IGL1), a novel gene encoded by a major QTL for modulating grain length in rice
Colon-Targeted Release of Turmeric Nonextractable Polyphenols and Their Anticolitis Potential via Gut Microbiota-Dependent Alleviation on Intestinal Barrier Dysfunction in Mice
Protective effects of aloin on asthmatic mice by activating Nrf2/HO-1 pathway and inhibiting TGF-β/Smad2/3 pathway
Identification of Cancer Stem Cell-related Gene by Single-cell and MachineLearning Predicts Immune Status, Chemotherapy Drug, and Prognosisin Lung Adenocarcinoma
Deep neural network for discovering metabolism-related biomarkers for lung adenocarcinoma
A comprehensive review on microbiome, aromas and flavors, chemical composition, nutrition and future prospects of Fuzhuan brick tea
Human Muse cells-derived neural precursor cells as the novel seed cells for the repair of spinal cord injury
<p>microRNA-612 suppresses the malignant development of non-small-cell lung cancer by directly targeting bromodomain-containing protein 4</p>
Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
Genetic variants in ADAM33 are associated with airway inflammation and lung function in COPD
Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids
[Clinical observation of home noninvasive positive pressure ventilation in hypercapnic patient with stable severe chronic obstructive pulmonary disease].
PubMed 2012cited by 3position: last